共 50 条
- [1] PHARMACOKINETICS AND SAFETY OUTCOMES OF COMPOUNDED VERSUS BRANDED TESTOSTERONE PELLETS IN MEN WITH TESTOSTERONE DEFICIENCY: A SINGLE-CENTER, OPEN-LABEL, RANDOMIZED TRIAL JOURNAL OF UROLOGY, 2023, 209 : E1141 - E1141
- [4] Patient Satisfaction with Oral Testosterone Undecanoate in Men Who Received Prior Testosterone Therapy: An Open-Label, Single-Center Clinical Trial WORLD JOURNAL OF MENS HEALTH, 2024, 42 (04): : 762 - 771
- [5] PATIENT SATISFACTION WITH ORAL TESTOSTERONE UNDECANOATE IN TESTOSTERONE-DEFICIENT MEN WITH PREVIOUS TESTOSTERONE THERAPY: AN OPEN-LABEL, SINGLE-CENTER, PHASE IV CLINICAL TRIAL JOURNAL OF UROLOGY, 2023, 209 : E1141 - E1141
- [6] PATIENT SATISFACTION WITH ORAL TESTOSTERONE UNDECANOATE (JATENZO) IN MEN WITH PREVIOUS TESTOSTERONE THERAPY: AN OPEN-LABEL SINGLE-CENTER PHASE IV CLINICAL TRIAL JOURNAL OF SEXUAL MEDICINE, 2023, 20
- [8] PATIENT SATISFACTION AFTER SWITCHING TO ORAL TESTOSTERONE UNDECANOATE IN MEN CURRENTLY RECEIVING TESTOSTERONE THERAPY: AN OPEN-LABEL SINGLE-CENTER PHASE IV CLINICAL TRIAL JOURNAL OF UROLOGY, 2022, 207 (05): : E592 - E592
- [10] Patient Satisfaction with Oral Testosterone Undecanoate in Men Who Received Prior Testosterone Therapy: An Open-Label, Single- Center Clinical Trial WORLD JOURNAL OF MENS HEALTH, 2024,